Posted: Mon Jun 01, 2009 1:15 pm
Uwe,
Please forward to me your Pittcon presentation, as you suggested.
wayne.way@sial.com
For independent, peer reviewed reference, see:
1)The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery . . .
by David Mallett (GSK), et al. in Journal of Pharmaceutical and Biomedical Analysis
2)Shell and small particles; Evaluation of new column technology
by Szabolcs Fekete (Gedeon Richter) in Journal of Pharmaceutical and Biomedical Analysis
3)Fused-core particle technology as an alternative to sub-2-um particles to achieve high separation efficiency with low backpressure
by Jennifer Cunliffe (Pfizer) in Journal of Separation Science
Please forward to me your Pittcon presentation, as you suggested.
wayne.way@sial.com
For independent, peer reviewed reference, see:
1)The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery . . .
by David Mallett (GSK), et al. in Journal of Pharmaceutical and Biomedical Analysis
2)Shell and small particles; Evaluation of new column technology
by Szabolcs Fekete (Gedeon Richter) in Journal of Pharmaceutical and Biomedical Analysis
3)Fused-core particle technology as an alternative to sub-2-um particles to achieve high separation efficiency with low backpressure
by Jennifer Cunliffe (Pfizer) in Journal of Separation Science